HIV Task Force
Task force leaders
Navneet Dhillon, United States
Nicola Petrosillo, Italy
Type of task force
Incorporation with the Infection and Pulmonary Vascular Task Force
Click here to see the kind of work the HIV pulmonary hypertension research group has been doing under the umbrella of the Infection and Pulmonary Vascular Task Force.
Historical of the HIV PVRI Task Force
The PVRI HIV-associated Pulmonary Hypertension Task Force has been one of the most important Task Forces of the PVRI since its creation in 2006/7.
The Task Force was represented at various PVRI conferences over the years, participating in posters presentations, lectures and webinars, thus increasing the awareness of infectious disease specialists dealing with these uncommon but dramatic pulmonary manifestations of HIV.
The main aim of the HIV Task Force was to collaborate with some of the most important infectious disease societies, such as the ESCMID (European Society of Clinical Microbiology and Infectious Diseases), on joint issues.
In 2010, during the ECCMID (European Congress of Clinical Microbiology and Infectious Diseases) Conference in Vienna, Austria, we organised a full PVRI-ECCMID joint session with PVRI and ECCMID speakers. A special issue on ‘Pulmonary Hypertension and Infections of Clinical Microbiology’ was later published, with all authors being PVRI members and the editor being the Task Force leader.
Aims & Achievements
Over the years, a lot of research on pulmonary hypertension (PH) and pulmonary manifestations of HIV have been carried out by the Task Force, which resulted in the publication of around 30 papers in various peer-reviewed journals.
Since HIV infection is not decreasing in terms of new infections, our mission remains to increase the awareness of HIV-associated pulmonary hypertension and to collaborate with HIV specialists, pulmonologists, cardiologists and basic scientists from all over the world to discuss current needs and future chemical and biomedical research directions.
- Over the next 10 years, we would like to measure the impact of the most powerful antiretroviral therapies on the occurrence of pulmonary hypertension, and to create and nurture international collaborations.
- In order to identify specific gaps in knowledge and resources available to clinicians caring for pulmonary manifestations of HIV, we would like to conduct a survey with all PVRI members and the wider PVRI network.
- In addition to this, we also aim to revamp the HIV-PH Task Force website to include information about registries of HIV-associated pulmonary hypertension in countries where there is a PVRI presence.
- Furthermore, a vital effort will be the recruitment of new international members to the HIV Task Force in order to increase our reach and impact on people suffering from pulmonary vascular disease around the world.